close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exelixis, Inc. - Common Stock (NQ:EXEL)

44.36 -0.01 (-0.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exelixis, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
20 21 Next >
News headline image
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside. 
Via MarketBeat
News headline image
Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip ↗
A sizable dip in the innovation-driven Nasdaq Composite is the perfect excuse for investors to pounce on some phenomenal deals. 
Via The Motley Fool
News headline image
8 Analysts Have This to Say About Exelixis ↗
 
Via Benzinga
News headline image
Exelixis (EXEL) Q1 2023 Earnings Call Transcript ↗
EXEL earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
Exelixis: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update
From Exelixis, Inc.
Via Business Wire
News headline image
What 9 Analyst Ratings Have To Say About Exelixis ↗
 
Via Benzinga
News headline image
Why Exelixis Stock Leaped More Than 4% Higher Today ↗
Oh, how some investors love stock buyback programs. 
Via The Motley Fool
News headline image
Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns ↗
Exelixis Inc's (NASDAQ: EXEL) board member Lance Willsey announced his resignation from the Board,  
Via Benzinga
News headline image
Farallon Capital Management Comments on Successful Campaign for Change at Exelixis
From Farallon Capital Management L.L.C.
Via Business Wire
News headline image
Exelixis Announces Departure of Lance Willsey, M.D. From Board of Directors
From Exelixis, Inc.
Via Business Wire
News headline image
Exelixis to Present at the BofA Securities 2023 Healthcare Conference on May 10, 2023
From Exelixis, Inc.
Via Business Wire
News headline image
Analyst Ratings for Exelixis ↗
 
Via Benzinga
News headline image
Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director Candidates
From Farallon Capital Management L.L.C.
Via Business Wire
News headline image
Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders
From Exelixis, Inc.
Via Business Wire
News headline image
Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023
From Exelixis, Inc.
Via Business Wire
News headline image
The Smartest Stocks to Buy With $20 Right Now and Hold Forever ↗
These cheap stocks have the potential to skyrocket over the long haul. 
Via The Motley Fool
News headline image
Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip ↗
Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite. 
Via The Motley Fool
News headline image
Exelixis Advances Board Refreshment Plan
From Exelixis, Inc.
Via Business Wire
News headline image
Exelixis Reiterates Commitment to Shareholder Value Creation
From Exelixis, Inc.
Via Business Wire
News headline image
2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗
Both companies have game-changing product portfolios that should result in stock price growth. 
Via The Motley Fool
News headline image
Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors ↗
 
Via Benzinga
News headline image
Farallon Issues Letter to Exelixis Board of Directors Outlining Case for Change
From Farallon Capital Management L.L.C.
Via Business Wire
News headline image
2 Incredible Stocks to Buy With Less Than $25 ↗
Nothing beats a great investment for the price of just a few cups of coffee. 
Via The Motley Fool
News headline image
Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark ↗
In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier. 
Via Investor's Business Daily
News headline image
Exelixis Announces $550 Million Share Repurchase Program
From Exelixis, Inc.
Via Business Wire
News headline image
3 Beaten-Down Stocks That Could Soar This Year ↗
These stocks could enjoy big rebounds in 2023. 
Via The Motley Fool
News headline image
Exelixis Stock Generating Improved Relative Strength Rating ↗
Exelixis stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 69 to 76. 
Via Investor's Business Daily
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today